EP3321359
Tilbrigðisform af úrat-oxíðasa og notkun á þeim
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.4.2006EP published:
2.12.2020EP application number:
17192971.4
EP translation filed:
2.3.2021Grant published:
15.3.2021EPO information:
European Patent Register
Max expiry date:
10.4.2026Expiry date:
10.4.2026
Title:
VARIANT FORMS OF URATE OXIDASE AND USE THEREOF
Timeline
Today
11.4.2006EP application
2.12.2020EP Publication
2.3.2021Translation submitted
15.3.2021Registration published
10.4.2026Expires
Owner
Name:
Horizon Therapeutics USA, Inc.Address:
1 Horizon Way, Deerfield, Illinois 60015, US
Inventor
Name:
HARTMAN, JacobAddress:
58453 Holon, IL
Name:
MENDELOVITZ, SimonaAddress:
69341 Ramat Aviv, IL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
670573 PDate:
11.4.2005Country:
US
Classification
Categories:
C12N 9/06, A61K 47/60
Annual fees
Number
Paid
Expires
Payer
Number: 16
Paid: 18.3.2021
Expires: 10.4.2022
Payer: Sigurjónsson & Thor ehf.
Number: 17
Paid: 21.3.2022
Expires: 10.4.2023
Payer: Patice ehf.
Number: 18
Paid: 27.4.2023
Expires: 10.4.2024
Payer: Maxval Group
Number: 19
Paid: 26.4.2024
Expires: 10.4.2025
Payer: Maxval Group, Inc.
Number: 20
Paid: 8.4.2025
Expires: 10.4.2026
Payer: Árnason Faktor ehf.